Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

Laser-microdissection (LMD) validation of three deletions on Chromosome 3, 14, and 16 in normal cells from sample MS168-UM-EU. (A) A representative image of normal breast parenchyma (hematoxylin and eosin staining) in thin frozen section from specimen MS168-UM-EU, with a normal duct. (B,C) Images before and after the normal structures have been dissected by laser and collected. The thick frozen sections (16–20 µm) in B and C have been stained with cresyl violet. The green irregular circle in B shows the area marked for dissection by laser. (D,E) Genetic copy number profiles of chromosomes with aberrations (in red) and without (in blue) from SNP arrays. The profile in D has been produced using the bulk DNA derived from all cells in sample MS168-UM-EU, while the profile in E is derived from DNA isolated from microdissected cells. Sample MS168-UM-EU shows deletions present in ∼5%–15% of cells, as indicated by the BAF values deviating from the value of 0.5. The corresponding number of cells affected by deletions in sample MS168-UM-EU-LMD is higher, suggesting an enrichment of cells with aberrations. The combined load of deletions on Chromosomes 3, 14, and 16 in the sample MS168-UM-EU is 92.8 Mb. Interestingly, the microdissected sample MS168-UM-EU-LMD contains also a low proportion of cells (∼5%–10%) with a copy number neutral loss of heterozygozity (CNNLOH) of whole Chromosome 22, which was not detectable in the bulk DNA derived from all cells in sample MS168-UM-EU.

This Article

  1. Genome Res. 25: 1521-1535

Preprint Server